Pfizer and BioNTech delay FDA request for children under 5

Pfizer and BioNTech are delaying their application to the Food and Drug Administration (FDA) for authorization of their Chinese coronavirus vaccine for children under five, the company announced on Friday.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button